LX211 highlighted as potential disease modifying therapy for non...

Courtesy EurekAlert! - Chemistry, Physics and Materials Sciences  Sun, 10/25/2009 - 22:00

(Kureczka/Martin Associates) LX211 (LUVENIQ; oral voclosporin) may become the first approved oral treatment capable of modifying the course of uveitis, otherwise inevitably associated with severe vision loss or substantial morbidity from steroid use.

Phase 2/3 trial results highlight LX211's ability to control inflammation characterizing this potentially blinding eye disease and significantly reduce its rate of recurrence.

Lux Biosciences plans to file for marketing approvals around year-end 2009 and early 2010 in the United States and Europe, respectively.

Tags:

 

More related items

Blocking protein may prevent blinding disease
(Medical College of Georgia) Blocking a protein that battles infection may help thwart a common cause of vision loss in chronic diseases such as diabetes, Medical College of Georgia...

Steroid Injections May Help Restore Vision In Some...
Injecting the eye with the corticosteroid triamcinolone appears effective in improving the vision of some patients with retinal vein occlusion, an important cause of vision loss that results...

Steroid injections may help restore vision in some...
(JAMA and Archives Journals) Injecting the eye with the corticosteroid triamcinolone appears effective in improving the vision of some patients with retinal vein occlusion, an important cause...

Teaming with Microbes: A Gardener's Guide to the Soil...
Smart gardeners know that soil is anything but an inert substance. Healthy soil is teeming with life-not just earthworms and insects, but a staggering multitude of bacteria, fungi, and other...

Biomaterials Science, Second Edition: An Introduction...
The second edition of this bestselling title provides the most up-to-date comprehensive review of all aspects of biomaterials science by providing a balanced, insightful approach to learning...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com